X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Natco Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. NATCO PHARMA FDC LTD./
NATCO PHARMA
 
P/E (TTM) x 17.3 33.0 52.5% View Chart
P/BV x 3.6 16.8 21.5% View Chart
Dividend Yield % 1.3 0.7 192.3%  

Financials

 FDC LTD.   NATCO PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
NATCO PHARMA
Mar-14
FDC LTD./
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs144877 16.4%   
Low Rs79424 18.7%   
Sales per share (Unadj.) Rs47.6223.4 21.3%  
Earnings per share (Unadj.) Rs7.631.1 24.5%  
Cash flow per share (Unadj.) Rs9.040.3 22.4%  
Dividends per share (Unadj.) Rs2.255.00 45.0%  
Dividend yield (eoy) %2.00.8 263.0%  
Book value per share (Unadj.) Rs47.5219.5 21.7%  
Shares outstanding (eoy) m177.8333.07 537.7%   
Bonus/Rights/Conversions BBPA-  
Price / Sales ratio x2.32.9 80.4%   
Avg P/E ratio x14.620.9 69.9%  
P/CF ratio (eoy) x12.316.1 76.5%  
Price / Book Value ratio x2.33.0 79.0%  
Dividend payout %29.616.1 183.7%   
Avg Mkt Cap Rs m19,78421,504 92.0%   
No. of employees `000NANA-   
Total wages/salary Rs m1,2211,128 108.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m8,4597,389 114.5%  
Other income Rs m394167 235.5%   
Total revenues Rs m8,8527,556 117.2%   
Gross profit Rs m2,0701,793 115.4%  
Depreciation Rs m249304 81.8%   
Interest Rs m31366 8.5%   
Profit before tax Rs m2,1841,290 169.3%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m606309 196.2%   
Profit after tax Rs m1,3531,027 131.7%  
Gross profit margin %24.524.3 100.8%  
Effective tax rate %27.723.9 115.9%   
Net profit margin %16.013.9 115.1%  
BALANCE SHEET DATA
Current assets Rs m4,3553,681 118.3%   
Current liabilities Rs m1,7923,123 57.4%   
Net working cap to sales %30.37.6 400.9%  
Current ratio x2.41.2 206.2%  
Inventory Days Days4489 49.7%  
Debtors Days Days2559 42.0%  
Net fixed assets Rs m3,0257,685 39.4%   
Share capital Rs m179331 54.0%   
"Free" reserves Rs m8,2436,670 123.6%   
Net worth Rs m8,4537,259 116.5%   
Long term debt Rs m11955 1.1%   
Total assets Rs m10,55711,957 88.3%  
Interest coverage x71.44.5 1,579.3%   
Debt to equity ratio x00.1 1.0%  
Sales to assets ratio x0.80.6 129.7%   
Return on assets %13.111.7 112.5%  
Return on equity %16.014.2 113.1%  
Return on capital %23.520.7 113.4%  
Exports to sales %13.339.4 33.8%   
Imports to sales %3.35.7 58.7%   
Exports (fob) Rs m1,1262,908 38.7%   
Imports (cif) Rs m283421 67.1%   
Fx inflow Rs m1,1463,445 33.3%   
Fx outflow Rs m355703 50.6%   
Net fx Rs m7912,743 28.8%   
CASH FLOW
From Operations Rs m1,4851,440 103.1%  
From Investments Rs m-620-1,089 56.9%  
From Financial Activity Rs m-753-353 213.4%  
Net Cashflow Rs m113-1 -7,570.5%  

Share Holding

Indian Promoters % 68.9 52.0 132.4%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 4.7 7.8 59.9%  
FIIs % 7.5 16.6 45.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 26.0 73.1%  
Shareholders   23,730 25,395 93.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   PANACEA BIOTECH  DISHMAN PHARMA  FULFORD INDIA  JUBILANT LIFE SCIENCES  DIVIS LABORATORIES  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Aug 22, 2017 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS